Table 1.

Groups of patients included in this study.

Group	Discovery Cohort	Validation Cohort
	N = 89	N = 126
controls (hydrocephalus)	19	21
glioblastoma	32	41
low-grade glioma	14	8
meningiomas	11	44
brain metastasis	13	12